Cardiovascular

Reversible ADP Antagonists: New Alternatives To Clopidogrel For Anti-Platelet Therapy In Elective PCI»

Deepak Bhatt

ORLANDO—Deepak Bhatt from the VA Boston Healthcare System and Brigham & Women's Hospital, talks with Peter Goodwin about findings from the CHAMPION-PLATFORM study (using cangrelor in PCI) and the PLATO study (with ticagrelor in ACS)—testing reversible ADP antagonist agents as anti-platelet therapy, as reported at the American Heart Association Annual Meeting held in Orlando.

Central Pressure And New Goals: Should Be Hypertension Therapy Priorities»

Björn Dahlöf

A fundamental change in the way hypertension is measured, and studies to identify evidence-based blood pressure goals have been highlighted as top priorities by one of Sweden's prominent hypertension specialists, Björn Dahlöf, during the European Meeting on Hypertension.

Oncology

Urgent Need To Change Cancer Research Priorities: Global Cancer Fund; Prevention; Surgical Innovation; Trans-National Research»
Richard Sullivan

Richard Sullivan

Richard Sullivan at ECCO15-ESMO34 on the need for cancer research which is more trans-national and for a Global Cancer Fund to prioritize prevention, surgical innovation, and more creative, outward branching research strategies to probe mechanisms such as metastasis.

Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality»
Mieke Van Hemelrijck

Mieke Van Hemelrijck

Mieke Van Hemelrijck at ECCO15-ESMO34 on findings that cardiovascular mortality from heart failure and arrhythmia in addition to ischemic heart disease and myocardial infarction increased among patients treated with endocrine therapy—of whatever type—for their prostate cancer.

Global Health

Richard Horton

At a briefing held simultaneously in London and Washington DC Richard Horton, Editor of The Lancet, Andy Haines, Director of the London School of Hygiene and Tropical Medicine, Anil Markandya from the Basque Centre for Climate Change in Bilbao, Spain, and Paul Wilkinson, James Woodcock and Alan Dangour from the London School tell Sarah Maxwell and Peter Goodwin about their findings, just published in a special edition of the Lancet, on the consequences to human health of mitigating the effects of greenhouse gas emissions. In agriculture and food, urban transportation, electricity generation and home energy use the Lancet data showed large positive effects on human health over the next few decades if we choose the right strategies to reduce greenhouse gas emissions.

Diadier Diallo

NAIROBI, KENYA: Diadier Diallo of the London School of Hygiene and Tropical Medicine, co-ordinator of a trial of intermittent preventive treatment (IPT) for children in Burkina Faso and Mali, told Peter Goodwin about the success of his group's study using full dose malaria treatment among children for prophylaxis, as reported at the 5th MIM Pan African Malaria Conference, Nairobi.